Top Rated Biotechnolgy Stocks-The Street, Clinical Data Bulls Bears

Image via Wikipedia

Top Rated Stocks: Biotechnology

Top Rated Stocks

01/27/11

Clinical Data Website

Clinical Data Pipeline

Clinical Data--Google Finance  CLDA

January 24, 2011

Clinical Data, Inc. Announces FDA Approval of Viibryd™ (vilazodone HCl) for Major Depressive Disorder

RSS Feed for Top Rated Stocks: Biotechnology

Every day TheStreet Ratings produces a list of the top rated stocks. Every day we will publish several lists to provide you with some stock buying (or selling) ideas.

Equity Top: Biotechnology

Symbol Equity Rating

EBS EMERGENT BIOSOLUTIONS INC A-

BIIB BIOGEN IDEC INC B+

AMGN AMGEN INC B+

ALXN ALEXION PHARMACEUTICALS INC B+

CBPO CHINA BIOLOGIC PRODUCTS INC B

SSRX 3SBIO INC -ADR B

UTHR UNITED THERAPEUTICS CORP B

SCLN SCICLONE PHARMACEUTICALS INC B

CBST CUBIST PHARMACEUTICALS INC B

CEPH CEPHALON INC B

Source: TSC Ratings

Drugs

Clinical Data: Bulls and Bears Round Two

1/25/11

NEWTON, Mass. (TheStreet) --Clinical Data (CLDA) scored a big victory with the approval of a new antidepressant, sending the stock price soaring 68% to $25.17 on Monday. Many of the company's shareholders and supporters, however, are looking for an even bigger payday when Clinical Data sells itself to the highest bidder.

Continued

Top Biotech Stocks for 2011 and January Catalyst Event Dates

Stocks Mentioned:  Dendreon, Human Genome Sciences, Eli Lilly, Cerus, Curis, Compugen, Spectrum Pharmaceuticals, Impax Laboratories, Exelixis, Medivation, Seattle Genetics, Corcept, PolyMedix, BioMarin, Endo Pharmaceuticals, DepoMed, Mannkind, Orexigen Therapeutics, AstraZeneca, Clinical Data

Here are the Top Biotech Picks for 2011, Stocks Highlighted at the JP Morgan Healthcare Conference, News on Human Genome Sciences, Dendreon, Bargain Biotech Stocks, and January FDA Catalysts.

5 Bargain Biotech Stocks for 2011
Street Picks

NEW YORK (InvestorPlace) -- On July 8, 2009, I recommended five cutting-edge medical products and biotech stocks. Even factoring in the single dud of the group, you would still have an average return of more than 110%.

Do I have your attention? Good, because I've put together a list of the hottest bargain biotech stocks to buy for 2011. Some of the names will look familiar because I think the stocks still have legs, while others have been swapped out for new names that I think have more potential in the year ahead.

Here are the best biotech stocks to own now:
Continued